On Monday, Tenaya Therapeutics Inc (NASDAQ: TNYA) opened lower -4.54% from the last session, before settling in for the closing price of $0.75. Price fluctuations for TNYA have ranged from $0.36 to $2.35 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -15.57% annually for the last half of the decade. Company’s average yearly earnings per share was noted 52.96% at the time writing. With a float of $203.28 million, this company’s outstanding shares have now reached $216.51 million.
Tenaya Therapeutics Inc (TNYA) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tenaya Therapeutics Inc is 6.11%, while institutional ownership is 14.48%. The most recent insider transaction that took place on Nov 17 ’25, was worth 1,818. In this transaction SVP, Finance of this company sold 1,367 shares at a rate of $1.33, taking the stock ownership to the 93,971 shares. Before that another transaction happened on Nov 17 ’25, when Company’s Chief Medical Officer sold 2,877 for $1.33, making the entire transaction worth $3,826. This insider now owns 169,926 shares in total.
Tenaya Therapeutics Inc (TNYA) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.28 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.31) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 52.96% per share during the next fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Check out the current performance indicators for Tenaya Therapeutics Inc (TNYA). In the past quarter, the stock posted a quick ratio of 4.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.49 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Let’s dig in a bit further. During the last 5-days, its volume was 4.55 million. That was better than the volume of 3.54 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 36.59%.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 4.34%, which indicates a significant decrease from 8.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0877 in the past 14 days, which was lower than the 0.1228 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2709, while its 200-day Moving Average is $0.9482. However, in the short run, Tenaya Therapeutics Inc’s stock first resistance to watch stands at $0.7465. Second resistance stands at $0.7732. The third major resistance level sits at $0.7964. If the price goes on to break the first support level at $0.6966, it is likely to go to the next support level at $0.6734. Assuming the price breaks the second support level, the third support level stands at $0.6467.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
There are currently 166,506K shares outstanding in the company with a market cap of 155.87 million. Presently, the company’s annual sales total 0 K according to its annual income of -111,130 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -20,280 K.
